www.gavi.org
Open in
urlscan Pro
2a04:4e42::449
Public Scan
Submitted URL: http://www.gavi.org/
Effective URL: https://www.gavi.org/
Submission: On May 22 via api from US — Scanned from DE
Effective URL: https://www.gavi.org/
Submission: On May 22 via api from US — Scanned from DE
Form analysis 2 forms found in the DOM
GET /search
<form action="/search" method="get" id="search-block-form" accept-charset="UTF-8" data-once="form-updated" data-drupal-form-fields="edit-keys">
<div class="js-form-item form-item form-type-search js-form-type-search form-item-s js-form-item-s form-no-label">
<label for="edit-keys" class="visually-hidden">Search</label>
<input title="Enter the terms you wish to search for." data-drupal-selector="edit-keys" type="search" id="edit-keys" name="s" value="" size="15" maxlength="128" class="form-search">
</div>
<div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"><input data-drupal-selector="edit-submit" type="submit" id="edit-submit" value="Search" class="button js-form-submit form-submit">
</div>
</form>POST /
<form
class="webform-submission-form webform-submission-add-form webform-submission-contact-form webform-submission-contact-add-form webform-submission-contact-node-74601-form webform-submission-contact-node-74601-add-form js-webform-details-toggle webform-details-toggle"
data-drupal-selector="webform-submission-contact-node-74601-add-form" action="/" method="post" id="webform-submission-contact-node-74601-add-form" accept-charset="UTF-8" data-once="form-updated webform-details-toggle"
data-drupal-form-fields="edit-first-name,edit-last-name,edit-email,edit-company,edit-country,edit-actions-submit,edit-url">
<button class="modal__close js-modal__close"></button>
<div class="js-form-item form-item form-type-textfield js-form-type-textfield form-item-first-name js-form-item-first-name form-no-label">
<label for="edit-first-name" class="visually-hidden js-form-required form-required">First Name</label>
<input data-webform-required-error="This Fields is Required." data-drupal-selector="edit-first-name" type="text" id="edit-first-name" name="first_name" value="" size="60" maxlength="255" placeholder="First Name" class="form-text required"
required="required" aria-required="true" data-once="webform-required-error">
</div>
<div class="js-form-item form-item form-type-textfield js-form-type-textfield form-item-last-name js-form-item-last-name form-no-label">
<label for="edit-last-name" class="visually-hidden js-form-required form-required">Last Name</label>
<input data-webform-required-error="This Field is Required." data-drupal-selector="edit-last-name" type="text" id="edit-last-name" name="last_name" value="" size="60" maxlength="255" placeholder="Last Name" class="form-text required"
required="required" aria-required="true" data-once="webform-required-error">
</div>
<div class="js-form-item form-item form-type-email js-form-type-email form-item-email js-form-item-email form-no-label">
<label for="edit-email" class="visually-hidden js-form-required form-required">Email</label>
<input data-webform-required-error="This field is required." data-drupal-selector="edit-email" type="email" id="edit-email" name="email" value="" size="60" maxlength="254" placeholder="name@email.com" class="form-email required"
required="required" aria-required="true" data-once="webform-required-error">
</div>
<div class="js-form-item form-item form-type-textfield js-form-type-textfield form-item-company js-form-item-company form-no-label">
<label for="edit-company" class="visually-hidden js-form-required form-required">Company</label>
<input data-webform-required-error="This Field is Required." data-drupal-selector="edit-company" type="text" id="edit-company" name="company" value="" size="60" maxlength="255" placeholder="Company" class="form-text required" required="required"
aria-required="true" data-once="webform-required-error">
</div>
<div class="js-form-item form-item form-type-textfield js-form-type-textfield form-item-country js-form-item-country form-no-label">
<label for="edit-country" class="visually-hidden js-form-required form-required">Country</label>
<input data-webform-required-error="This Field is Required." data-drupal-selector="edit-country" type="text" id="edit-country" name="country" value="" size="60" maxlength="255" placeholder="Country" class="form-text required" required="required"
aria-required="true" data-once="webform-required-error">
</div>
<input data-drupal-selector="edit-language" type="hidden" name="language" value="English">
<input data-drupal-selector="edit-recordtype" type="hidden" name="recordtype" value="01209000000miXmAAI">
<input data-drupal-selector="edit-debugemail" type="hidden" name="debugemail" value="dataintegration@gavi.org">
<input data-drupal-selector="edit-debug" type="hidden" name="debug" value="1">
<div data-drupal-selector="edit-captcha" class="captcha captcha-type-challenge--recaptcha">
<div class="captcha__element">
<input data-drupal-selector="edit-captcha-sid" type="hidden" name="captcha_sid" value="74880641">
<input data-drupal-selector="edit-captcha-token" type="hidden" name="captcha_token" value="akwRszW1E45h6VfmszAYEdz64VGPYbORXfsu7OvtTuo">
<input data-drupal-selector="edit-captcha-response" type="hidden" name="captcha_response" value="Google no captcha">
<div class="g-recaptcha" data-sitekey="6LdDJMwZAAAAAMFsKJRlI8L7sACZlVULqjoClv3S" data-theme="light" data-type="image">
<div style="width: 304px; height: 78px;">
<div><iframe title="reCAPTCHA" width="304" height="78" role="presentation" name="a-amr628vyscxy" frameborder="0" scrolling="no"
sandbox="allow-forms allow-popups allow-same-origin allow-scripts allow-top-navigation allow-modals allow-popups-to-escape-sandbox allow-storage-access-by-user-activation"
src="https://www.recaptcha.net/recaptcha/api2/anchor?ar=1&k=6LdDJMwZAAAAAMFsKJRlI8L7sACZlVULqjoClv3S&co=aHR0cHM6Ly93d3cuZ2F2aS5vcmc6NDQz&hl=en&type=image&v=joHA60MeME-PNviL59xVH9zs&theme=light&size=normal&cb=q5c89hpp0zrt"></iframe>
</div><textarea id="g-recaptcha-response" name="g-recaptcha-response" class="g-recaptcha-response"
style="width: 250px; height: 40px; border: 1px solid rgb(193, 193, 193); margin: 10px 25px; padding: 0px; resize: none; display: none;"></textarea>
</div><iframe style="display: none;"></iframe>
</div><input data-drupal-selector="edit-captcha-cacheable" type="hidden" name="captcha_cacheable" value="1">
</div>
</div>
<div data-drupal-selector="edit-actions" class="form-actions webform-actions js-form-wrapper form-wrapper" id="edit-actions--2"><input class="webform-button--submit button button--primary js-form-submit form-submit"
data-drupal-selector="edit-actions-submit" type="submit" id="edit-actions-submit" name="op" value="Subscribe">
</div>
<div id="edit-disclaimer" class="js-form-item form-item form-type-webform-markup js-form-type-webform-markup form-item-disclaimer js-form-item-disclaimer form-no-label">
<small>By clicking the "Subscribe" button, you are agreeing to receive the digital newsletter from Gavi, the Vaccine Alliance, agreeing to our <a href="/terms-use" target="_blank">terms of use</a> and have read
our <a href="/privacy-policy" target="_blank">privacy policy</a>.</small>
</div>
<input autocomplete="off" data-drupal-selector="form-n9j0b6cuw5b6xehvoburomyobo52yw1nxjra7jhr53k" type="hidden" name="form_build_id" value="form-N9j0b6Cuw5B6XeHVOBurOMYObo52Yw1nxJRA7JHR53k">
<input data-drupal-selector="edit-webform-submission-contact-node-74601-add-form" type="hidden" name="form_id" value="webform_submission_contact_node_74601_add_form">
<div class="url-textfield js-form-wrapper form-wrapper" style="display: none !important;">
<div class="js-form-item form-item form-type-textfield js-form-type-textfield form-item-url js-form-item-url">
<label for="edit-url">Leave this field blank</label>
<input autocomplete="off" data-drupal-selector="edit-url" type="text" id="edit-url" name="url" value="" size="20" maxlength="128" class="form-text">
</div>
</div>
</form>Text Content
X
Skip to main content
COUNTRY HUB
* Country portal | COVAX platform
SECONDARY NAV
* Gavi's next strategic period
* Protecting Our Future
* Ethics Hotline
DONATE
* Donate
* EN
* FR
MAIN NAVIGATION
Menu
* Our Alliance
Our Alliance
* About
* Strategy
* Vaccine Investment Strategy 2024
* Phase 6 (2026–2030)
* Phase 5 (2021–2025)
* The equity goal
* The healthy markets goal
* The sustainability goal
* The vaccine goal
* Phase 4 (2016–2020)
* The market shaping goal
* The sustainability goal
* The systems goal
* The vaccine goal
* Phase 3 (2011–2015)
* The financing goal
* The health systems goal
* The market shaping goal
* The vaccine goal
* Phase 2 (2006–2010)
* Phase 1 (2000–2005)
* Risk management
* Learning System Strategy
* Gender and immunisation
* Operating model
* Gavi's partnership model
* The Bill & Melinda Gates Foundation
* UNICEF
* WHO
* The World Bank Group
* Civil society: driving increased equity in immunisation
* Developing country governments
* Developing country pharmaceutical industry
* Industrialised country governments
* Industralised country pharmaceutical industry
* Research and technical institutes
* Gavi's business model
* Gavi Secretariat
* Gavi transparency portal and IATI
* Governance
* Gavi Board
* Board Committees
* Board composition
* Board members
* Board and Committee minutes
* Calendar
* Governance and legal structures
* Corporate Policies
* Audit and Investigations
* Market Shaping
* Vaccine Innovation Prioritisation Strategy
* Market Shaping roadmaps
* Product information for vaccines and cold chain equipment
* Vaccine demand forecasting
* Global health and development
* Decade of Vaccines Collaboration
* International Health Partnership for UHC 2030
* Millennium Development Goals
* Sustainable Development Goals
* UN Global Strategy for Women's, Children's and Adolescents' Health
* Climate, health and immunisation
* Global health security
* Work with us
* Culture
* Health equity and human rights
* Vacancies
* Internship programme
* RFPs and consulting opportunities
Keep informed about the latest topics in global health.
#VaccinesWork
FOCUS AREAS Zero-Dose Child Gavi Secretariat and leadership Progress report
Partners Our Board
--------------------------------------------------------------------------------
CAREERS Current vacancies Internship programme RFPs and consulting
--------------------------------------------------------------------------------
Contact us ISO certification Phishing and fraud
* Programmes & Impact
Programmes & Impact
* How our support works
* Gavi Support Guidelines
* Independent Review Committee
* Joint appraisals
* Country portal and COVAX collaboration platform
* Types of support
* Vaccine support
* COVID-19 vaccines
* Human papillomavirus
* Inactivated polio vaccine
* Japanese encephalitis
* Measles and measles-rubella
* Meningitis A
* Oral cholera
* Pentavalent
* Pneumococcal
* Rotavirus
* Typhoid
* Yellow fever
* Health system and immunisation strengthening
* Immunisation supply chain
* Data
* Leadership, management and coordination
* Learning and Performance Management (LPM)
* Demand promotion
* Partners' Engagement Framework
* Targeted country assistance
* Strategic focus areas
* Foundational support
* Making immunisation sustainable
* Eligibility
* Gavi’s approach to engaging with middle-income countries
* Co-financing
* Civil society organisation
* Country Hub
* Africa
* Angola
* Benin
* Burkina Faso
* Burundi
* Cameroon
* Central African Republic (the)
* Chad
* Comoros
* Congo
* Congo, DR
* Côte d’Ivoire
* Eritrea
* Ethiopia
* Gambia
* Ghana
* Guinea
* Guinea-Bissau
* Kenya
* Lesotho
* Liberia
* Madagascar
* Malawi
* Mali
* Mauritania
* Mozambique
* Niger
* Nigeria
* Rwanda
* Sao Tome and Principe
* Senegal
* Sierra Leone
* South Sudan
* Tanzania, UR
* Togo
* Uganda
* Zambia
* Zimbabwe
* Americas
* Bolivia
* Cuba
* Guyana
* Haiti
* Honduras
* Nicaragua
* Eastern Mediterranean
* Afghanistan
* Djibouti
* Pakistan
* Somalia
* Sudan
* Yemen
* Europe
* Albania
* Armenia
* Azerbaijan
* Bosnia & Herzegovina
* Georgia
* Kyrgyzstan
* Moldova
* Tajikistan
* Turkmenistan
* Ukraine
* Uzbekistan
* South-East Asia
* Bangladesh
* Bhutan
* India
* Indonesia
* Korea, DPR
* Myanmar
* Nepal
* Sri Lanka
* Timor Leste
* Western Pacific
* Cambodia
* China
* Kiribati
* Lao PDR
* Mongolia
* Papua New Guinea
* Solomon islands
* Vietnam
* Our impact
* Digital health information (DHI)
* Measuring our performance
* 2011–2015 indicators
* 2016–2020 indicators
* 2021–2025 indicators
* Countries approved for support
* Evaluation studies
* Facts and figures
* Progress reports
* Programmatic policies
* Co-financing policy
* Fragility, emergencies and displaced populations policy
* Gender policy
* Health system and immunisation strengthening policy
* Prioritisation mechanism
* Risk policy
* Self-procurement policy
* Transparency and accountability
* Vaccine donation policy
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible country
Explore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
COVID-19
* Investing in Gavi
Investing in Gavi
* Resource mobilisation process
* Protecting Our Future: The Global Forum for Vaccine Sovereignty and
Innovation
* The Gavi COVAX AMC 2022 Investment Opportunity
* Gavi COVAX AMC Summit 2021
* Raising Generation immUnity: Global vaccine impact conference
* Gavi COVAX AMC Investment Opportunity 2021 Launch Event
* Global Vaccine Summit 2020
* Gavi's Investment Opportunity launch meeting, 30 August 2019
* Gavi Mid-Term Review, Abu Dhabi high level conference, 10-11 December
2018
* Previous events
* Gavi pledging conference January 2015
* Gavi replenishment launch meeting May 2014
* Gavi Mid-Term Review meeting October 2013
* Gavi pledging conference June 2011
* Call for Action and Resources October 2010
* Financing Country Demand March 2010
* Funding
* Overview 2000–2037
* Current period 2021–2025
* Donor profiles
* AerCap Ireland Limited
* Children’s Investment Fund Foundation (CIFF)
* Church of Jesus Christ of Latter-day Saints
* Croda Foundation
* Eleanor Crook Foundation
* Integrate Health
* KSrelief
* Omnicom
* Power of Nutrition
* Scotland
* Airtel Nigeria
* Al Ansari Exchange
* Alight Solutions
* Alwaleed Philanthropies
* Analog Devices Foundation
* Arm Limited
* Asia Philanthropy Circle (APC)
* Audacious Alliance
* Australia
* Austria
* Bahrain
* Belgium
* Bhutan
* The Bill & Melinda Gates Foundation
* Blackberry
* Brazil
* Burkina Faso
* Cameroon
* Canada
* Centene Charitable Foundation
* China
* Cisco
* Coca-Cola Foundation
* CODE (RED) Campaign
* Collins Aerospace (Goodrich Corporation)
* Colombia
* Croatia
* Denmark
* Dolby Laboratories Charitable Fund
* ELMA Vaccines & Immunization Foundation
* Epiroc AB
* Estonia
* Etsy
* European Commission
* Finland
* France
* Germany
* Girl Effect
* Google.org
* Greece
* HH Sheikh Mohammed bin Zayed Al Nahyan
* Iceland
* India
* International Federation of Pharmaceutical Wholesalers
* Ireland
* Italy
* Japan
* Gamers Without Borders
* Kuwait
* ”la Caixa” Foundation
* Laerdal
* Liechtenstein
* Luxembourg
* Malaysia
* Malta
* Mastercard
* Mauritius
* McHugh O'Donovan Foundation
* Mexico
* Monaco
* Netherlands
* New Zealand
* Niger
* Norway
* Oman
* Orange
* Other private donors
* Pager Duty
* Philippines
* Poland
* Portugal
* Pratt & Whitney
* Proctor & Gamble
* Qatar
* Reed Hastings and Patty Quillin
* Republic of Korea
* Republic of Moldova
* Rockefeller Foundation
* Russell Reynolds Associates
* Russian Federation
* Salesforce
* Saudi Arabia
* Shell International
* Singapore
* Slovenia
* SMBC Aviation Capital Limited
* South Africa
* Spain
* Spotify
* Stanley Black & Decker
* Sweden
* Switzerland
* SymAsia Foundation
* Thistledown Foundation
* TikTok
* Toyota Tsusho
* Twilio
* Uganda
* UBS Optimus Foundation
* Unilever
* United Kingdom
* United States of America
* UPS
* Vaccine Forward Initiative
* Viet Nam
* The Visa Foundation
* WHO Foundation-Go Give One Campaign
* Wise
* Workday Foundation
* Partnering with business
* Innovative financing
* IFFIm
* Pneumococcal AMC
* About the pneumococcal AMC
* How it works
* Manufacturers
* How countries can apply
* Timeline
* Independent Assessment Committee
* AMC legal agreements
* Gavi Matching Fund
* Loan buydown
* INFUSE
* INFUSE community
* Call for innovations
The Global Vaccine Impact Conference explained
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
* VaccinesWork
VaccinesWork
* About VaccinesWork
* The science behind COVID-19
* Emerging threats
* Tales from the past
* News from the lab
* Stories from the community
FEATURED STORY
Everything you need to know about Gavi's incoming CEO, Dr Sania Nishtar
Read article
* News & Resources
News & Resources
* Media room
* News releases
* Media contacts
* Leadership biographies
* Publications
* Document library
* COVAX data brief
* COVID-19 situation reports
* Evaluations
* IRC reports
* Financial reports
* Knowledge products
KEY PUBLICATION
The 2023 Mid-Term Review Report
PROGRESS REPORT
* The Break COVID Now Summit
Search
* EN
* FR
Back to
OUR STRATEGY
Gavi's 2021–2025 strategy aims to help immunise 300 million children worldwide
with routine vaccines, averting 7–8 million deaths, with a focus on reaching
zero-dose children and missed communities.
Read our strategy
Back to
OUR STRATEGY
Gavi's 2021–2025 strategy aims to help immunise 300 million children worldwide
with routine vaccines, averting 7–8 million deaths, with a focus on reaching
zero-dose children and missed communities.
Read our strategy
Back to
NEW DATA SHOWS VACCINES HAVE SAVED 154 MILLION LIVES IN THE PAST 50 YEARS
An analysis of the impact of 50 years of the global vaccine programme shows the
extraordinary value of vaccination.
Read the article
Back to
NEW DATA SHOWS VACCINES HAVE SAVED 154 MILLION LIVES IN THE PAST 50 YEARS
An analysis of the impact of 50 years of the global vaccine programme shows the
extraordinary value of vaccination.
Read the article
Back to
THE MALARIA VACCINE: A VACCINESWORK GUIDE
Read all the news, explainers and features from our VaccinesWork writers on the
historic roll-out of the world's first malaria vaccine.
Explore
Back to
THE MALARIA VACCINE: A VACCINESWORK GUIDE
Read all the news, explainers and features from our VaccinesWork writers on the
historic roll-out of the world's first malaria vaccine.
Explore
Back to
ONE BILLION IMMUNISED BUT CHALLENGES AHEAD: READ GAVI’S 2022 ANNUAL PROGRESS
REPORT
Welcome to Gavi’s 2022 Annual Progress Report, the second of the 2021–2025
strategic period.
View report
Back to
ONE BILLION IMMUNISED BUT CHALLENGES AHEAD: READ GAVI’S 2022 ANNUAL PROGRESS
REPORT
Welcome to Gavi’s 2022 Annual Progress Report, the second of the 2021–2025
strategic period.
View report
Back to
ABOUT OUR ALLIANCE
As part of its mission to save lives and protect people’s health by increasing
equitable and sustainable use of vaccines, Gavi has helped vaccinate more than 1
billion children in 78 lower-income countries, averting more than 17.3 million
future deaths.
Who we are
Back to
ABOUT OUR ALLIANCE
As part of its mission to save lives and protect people’s health by increasing
equitable and sustainable use of vaccines, Gavi has helped vaccinate more than 1
billion children in 78 lower-income countries, averting more than 17.3 million
future deaths.
Who we are
Back to
OUR STRATEGY
Gavi's 2021–2025 strategy aims to help immunise 300 million children worldwide
with routine vaccines, averting 7–8 million deaths, with a focus on reaching
zero-dose children and missed communities.
Read our strategy
Back to
OUR STRATEGY
Gavi's 2021–2025 strategy aims to help immunise 300 million children worldwide
with routine vaccines, averting 7–8 million deaths, with a focus on reaching
zero-dose children and missed communities.
Read our strategy
Back to
NEW DATA SHOWS VACCINES HAVE SAVED 154 MILLION LIVES IN THE PAST 50 YEARS
An analysis of the impact of 50 years of the global vaccine programme shows the
extraordinary value of vaccination.
Read the article
Back to
NEW DATA SHOWS VACCINES HAVE SAVED 154 MILLION LIVES IN THE PAST 50 YEARS
An analysis of the impact of 50 years of the global vaccine programme shows the
extraordinary value of vaccination.
Read the article
Back to
THE MALARIA VACCINE: A VACCINESWORK GUIDE
Read all the news, explainers and features from our VaccinesWork writers on the
historic roll-out of the world's first malaria vaccine.
Explore
Back to
THE MALARIA VACCINE: A VACCINESWORK GUIDE
Read all the news, explainers and features from our VaccinesWork writers on the
historic roll-out of the world's first malaria vaccine.
Explore
Back to
ONE BILLION IMMUNISED BUT CHALLENGES AHEAD: READ GAVI’S 2022 ANNUAL PROGRESS
REPORT
Welcome to Gavi’s 2022 Annual Progress Report, the second of the 2021–2025
strategic period.
View report
Back to
ONE BILLION IMMUNISED BUT CHALLENGES AHEAD: READ GAVI’S 2022 ANNUAL PROGRESS
REPORT
Welcome to Gavi’s 2022 Annual Progress Report, the second of the 2021–2025
strategic period.
View report
Back to
ABOUT OUR ALLIANCE
As part of its mission to save lives and protect people’s health by increasing
equitable and sustainable use of vaccines, Gavi has helped vaccinate more than 1
billion children in 78 lower-income countries, averting more than 17.3 million
future deaths.
Who we are
Back to
ABOUT OUR ALLIANCE
As part of its mission to save lives and protect people’s health by increasing
equitable and sustainable use of vaccines, Gavi has helped vaccinate more than 1
billion children in 78 lower-income countries, averting more than 17.3 million
future deaths.
Who we are
Back to
OUR STRATEGY
Gavi's 2021–2025 strategy aims to help immunise 300 million children worldwide
with routine vaccines, averting 7–8 million deaths, with a focus on reaching
zero-dose children and missed communities.
Read our strategy
Back to
OUR STRATEGY
Gavi's 2021–2025 strategy aims to help immunise 300 million children worldwide
with routine vaccines, averting 7–8 million deaths, with a focus on reaching
zero-dose children and missed communities.
Read our strategy
* 1
* 2
* 3
* 4
* 5
TOP NEWS
View all
17 May 2024
Lao PDR and partners commence nationwide measles and rubella vaccination
campaign
The Lao People’s Democratic Republic (PDR), in collaboration with its partners,
today launched a crucial nationwide measles and rubella (MR) vaccination
campaign.
Read more
10 May 2024
Gavi and Government of Lesotho announce resumption of direct funding
Gavi, the Vaccine Alliance and the Government of Lesotho have signed a Letter of
Intent on the resumption of direct funding to the Government of Lesotho,
following the successful implementation of pre-disbursement financial systems
requirements…
Read more
25 April 2024
Major step in malaria prevention as three West African countries roll out
vaccine
In a significant step forward for malaria prevention in Africa, three countries
– Benin, Liberia and Sierra Leone – today launched a large-scale rollout of the
life-saving malaria vaccine targeting millions of children across the three
West…
Read more
Vaccines are one of the most successful and cost-effective health investments in
history with wider benefits that accrue across a lifetime.
Keep informed about the latest topics in global health, including top stories
related to the ongoing coronavirus (COVID-19) outbreak.
Visit page
Vaccines are one of the most successful and cost-effective health investments in
history with wider benefits that accrue across a lifetime.
Keep informed about the latest topics in global health, including top stories
related to the ongoing coronavirus (COVID-19) outbreak.
Visit page
TOP VACCINESWORK STORIES
View all stories
21 May 2024
Spread of deadlier mpox strain in DRC could pose global threat
CDC says urgent action is needed to contain an ongoing outbreak of clade I mpox
in the Democratic Republic of the Congo (DRC).
Mpox
Read article
17 May 2024
Six things you need to know about how vaccines can help prevent antimicrobial
resistance
Treating infections can drive antimicrobial resistance; using vaccines to
prevent infection can be crucial to reduce resistance and save lives.
Antimicrobial resistanceRoutine immunisation
Read article
15 May 2024
Cameroon hits back at yellow fever
Recent years have brought a yellow fever resurgence to Cameroon. Last month, a
targeted vaccination campaign pummeled the chain of transmission in seven
especially vulnerable health districts. Nalova Akua reports.
Yellow fever
Read article
VACCINES SUPPORT
Gavi supports vaccines against 20 infectious diseases, including COVID-19,
Ebola, malaria and rabies. Learn more about our support for each vaccine by
clicking below.
Visit page
Gavi supports vaccines against 20 infectious diseases, including COVID-19,
Ebola, malaria and rabies. Learn more about our support for each vaccine by
clicking below.
Visit page
OUR IMPACT
>1 billion children vaccinated through routine programmes
>17.3 million future deaths averted
19 countries fully self-financing
>220.5 US$ billion in economic benefits for countries
1.8 billion vaccinations through preventive vaccination campaigns
OUR MISSION: SAVE LIVES AND PROTECT PEOPLE'S HEALTH
Saving lives and protecting people’s health by increasing equitable and
sustainable use of vaccines.
Visit page
Saving lives and protecting people’s health by increasing equitable and
sustainable use of vaccines.
Visit page
OUR PARTNERS
Gavi draws on the skills of a variety of partners, combining the technical
expertise of the development community with the business know-how of the private
sector.
Meet the Vaccine Alliance partners
Gavi draws on the skills of a variety of partners, combining the technical
expertise of the development community with the business know-how of the private
sector.
Meet the Vaccine Alliance partners
SUBSCRIBE TO OUR NEWSLETTER
Subscribe
First Name
Last Name
Email
Company
Country
By clicking the "Subscribe" button, you are agreeing to receive the digital
newsletter from Gavi, the Vaccine Alliance, agreeing to our terms of use and
have read our privacy policy.
Leave this field blank
FOOTER
* Our Alliance
* Programmes & impact
* Investing in Gavi
* VaccinesWork
* News & resources
COUNTRY HUB
* Country portal | COVAX platform
DONATE
* Donate
FOOTER NAV
* Careers
* Contact
* Ethics hotline
* IFFIm
* Privacy Policy
* Terms of use
* Phishing and fraud
© Gavi 2024
* Gavi LinkedIn
* Gavi Twitter
* Gavi Instagram
* Gavi Facebook
* Gavi YouTube
* Gavi TikTok
Our achievements are thanks to the support and expertise of our founding
partners
WE USE NECESSARY COOKIES TO MAKE THIS SITE WORK. WE ALSO USE (WITH YOUR CONSENT)
ADDITIONAL COOKIES TO COLLECT INFORMATION WHEN YOU INTERACT WITH THE SITE TO
ENHANCE YOUR EXPERIENCE.
By clicking "Accept All", you consent to the use of these additional cookies.
You can change your settings by clicking "Manage Cookies." For more information,
please read our "Privacy Policy".
Necessary cookies
These cookies are essential for our website to function properly and cannot be
rejected via our website’s cookie notice. These cookies enable basic
functionality like page navigation, language preferences and page resources.
Without these cookies, the website cannot function properly and may not be able
to provide the services and features you expect. Therefore, they are always
enabled and cannot be turned off. By using our website, you agree that we can
place these types of cookies on your device.
Performance cookies
These cookies collect anonymous information about how visitors use our website,
for instance which pages visitors go to most often. This helps us to analyse
data about web page traffic and improve our site in order to tailor it to
visitor needs. We only use this information for statistical analysis purposes to
help improve the performance of our site; these cookies cannot be used to
identify individuals. All information these cookies collect is aggregated.
Targeting cookies
These cookies help us to collect anonymous data about how users interact with
our website and connect this to digital marketing and advertising campaigns on
other platforms. This information helps us to evaluate marketing and advertising
performance and make improvements. These cookies can be optionally accepted via
our website’s cookie notice. They will not be set on your device until you
consent to them. All information these cookies collect is aggregated and
anonymous: we do not collect or send any personally identifiable information via
these cookies.
Manage cookies Accept only necessary Accept all Save preferences Withdraw
consent